GSK — GlaxoSmithKline PLC Sp ADR

Ownership history in Clean Yield Group  ·  40 quarters on record

This page tracks every 13F SEC filing in which Clean Yield Group reported a position in GlaxoSmithKline PLC Sp ADR (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.76% (2022 Q2)
Avg. % of fund
1.44%
First filed
2013 Q3
Last filed
2025 Q4
Quarters held
40
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 161,357 -2,435 -1.5% 2.20% $7.9M $48.65
2025 Q3 REDUCED 163,792 -3,596 -2.1% 2.00% $7.1M $42.44
2025 Q2 REDUCED 167,388 -11,726 -6.5% 1.92% $6.4M $37.35
2025 Q1 REDUCED 179,114 -20,949 -10.5% 2.26% $6.9M $37.25
36 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GSK price (monthly, adj. close)

Other funds also holding GSK

As of 2025 Q4 — sorted by position size

Eversept Partners, LP 3Y 7Y 6.62% Mondrian Investment Partners LTD 3Y 7Y 4.7% EQUITY INVESTMENT CORP 3Y 7Y 4.07% Callodine Capital Management, LP 3Y 7Y 3.96% Hillman Capital Management, Inc. 3Y 7Y 3.53% KEATING INVESTMENT COUNSELORS INC 3Y 7Y 2.45% MILLER HOWARD INVESTMENTS INC /NY 3Y 7Y 2.43% NIA IMPACT ADVISORS, LLC 3Y 2.08% Altrius Capital Management Inc 3Y 2.05% ADVISORY RESEARCH INC 3Y 7Y 2.0%
← Back to Clean Yield Group Holdings